Bigora Sian
SEC insider (Form 3/4/5 filer). CIK 0001799365. Chief Development Officer at Processa Pharmaceuticals, Inc. (PCSA). 10 reported Form 4/5 transactions since Sep 2024; latest on Apr 30, 2026. Located in VERO BEACH, FL.
Companies Bigora Sian has filed insider reports for
- Processa Pharmaceuticals, Inc. (PCSA): Officer, Chief Development Officer
Bigora Sian
CIK: 0001799365
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Processa Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Apr 30, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2K shares at avg. $2.71$5K - Apr 30, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2K shares at avg. $2.69$5K - Apr 15, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect1.8K shares at avg. $2.97$5K - Mar 31, 2026PCSA
Processa Pharmaceuticals, Inc.
PurchaseDirect2.1K shares at avg. $2.54$5K - Jan 1, 2026PCSA
Processa Pharmaceuticals, Inc.
ExerciseDirect249 shares- - Oct 1, 2025PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
96K shares- - Oct 1, 2025PCSA
Processa Pharmaceuticals, Inc.
AwardDirectStock Options (Right to Buy)
288K shares- - Jul 24, 2025PCSA
Processa Pharmaceuticals, Inc.
AwardDirectRestricted Stock Units
1.7M shares- - Apr 1, 2025PCSA
Processa Pharmaceuticals, Inc.
Tax PaymentDirect3.3K shares at avg. $0.41$1K - Apr 1, 2025PCSA
Processa Pharmaceuticals, Inc.
ExerciseDirect15.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 30, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,971 | $2.71 | $5,341 | Direct |
| Apr 30, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,986 | $2.69 | $5,342 | Direct |
| Apr 15, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 1,799 | $2.97 | $5,343 | Direct |
| Mar 31, 2026 | PCSA Processa Pharmaceuticals, Inc. | Purchase | 2,107 | $2.54 | $5,341 | Direct |
| Jan 1, 2026 | PCSA Processa Pharmaceuticals, Inc. | Exercise | 249 | - | $0 | Direct |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock Units | 96,000 | - | - | Direct |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award Stock Options (Right to Buy) | 288,000 | - | - | Direct |
| Jul 24, 2025 | PCSA Processa Pharmaceuticals, Inc. | Award Restricted Stock Units | 1,659,185 | - | - | Direct |
| Apr 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Tax Payment | 3,311 | $0.41 | $1,364 | Direct |
| Apr 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | Exercise | 15,059 | - | - | Direct |
1-10 of 10 transactions